Stempoint Capital’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.8M Buy
+2,050,698
New +$11.7M 1.93% 18

Other funds holding ACRS

Stempoint Capital's ACRS Position: Q3 2026 in Review

Stempoint Capital opened a new position in Aclaris Therapeutics (ACRS) in Q3 2026: 2,050,698 shares worth $10.8M. The stake represents 1.93% of the portfolio and ranks #18 among its holdings.

167 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.

  • Stempoint Capital held 2,050,698 shares of Aclaris Therapeutics worth $10.8M as of Q3 2026.
  • Aclaris Therapeutics was a new Stempoint Capital position in Q3 2026.
  • Aclaris Therapeutics made up 1.93% of Stempoint Capital's portfolio in Q3 2026, its #18 holding.
  • 167 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.

Based on Stempoint Capital's 13F filing for Q3 2026, filed 16 Nov 2026.